Concourse Financial Group Securities’s VanEck Biotech ETF BBH Stock Holding History

Concourse Financial Group Securities’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11	Closed	-$1.82K	–	2308
2023 Q4	$1.82K	Hold	11	–	–	﹤0.01%	2033
2023 Q3	$1.71K	Hold	11	–	–	﹤0.01%	2023
2023 Q2	$1.72K	Hold	11	–	–	﹤0.01%	2043
2023 Q1	$1.78K	Sell	11 -10	-48%	-$1.62K	﹤0.01%	2075
2022 Q4	$3.35K	Hold	21	–	–	﹤0.01%	1943
2022 Q3	$3K	Hold	21	–	–	﹤0.01%	1721
2022 Q2	$3K	Hold	21	–	–	﹤0.01%	1943
2022 Q1	$3K	Buy	+21	New	+$3.4K	﹤0.01%	1939

Other funds holding BBH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $1.15B AUM 55.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Concourse Financial Group Securities's BBH Position: Q1 2024 in Review

Concourse Financial Group Securities sold out of VanEck Biotech ETF (BBH) in Q1 2024, closing a stake of 11 shares — an estimated $1.82K sold.

Concourse Financial Group Securities first reported a position in BBH in Q1 2022 and held it in 8 quarters. The position peaked at $3.35K in Q4 2022. 113 funds tracked by Wall St. Rank hold BBH as of Q1 2024.

Concourse Financial Group Securities reported no remaining VanEck Biotech ETF position as of Q1 2024 after selling out during the quarter.
Concourse Financial Group Securities sold 11 VanEck Biotech ETF shares in Q1 2024, an estimated $1.82K.
Concourse Financial Group Securities first reported a position in VanEck Biotech ETF in Q1 2022 and held it in 8 quarters.
Concourse Financial Group Securities's VanEck Biotech ETF position peaked at $3.35K in Q4 2022.
113 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2024.

Based on Concourse Financial Group Securities's 13F filing for Q1 2024, filed 1 May 2024.